Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:21:24 UTC 2023
by
admin
on
Sat Dec 16 16:21:24 UTC 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
19OWO1T3ZE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175616
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
||
|
NCI_THESAURUS |
C1660
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
||
|
NDF-RT |
N0000175615
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
||
|
WHO-ATC |
J05AX07
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
||
|
WHO-VATC |
QJ05AX07
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
FUZEON (AUTHORIZED: HIV INFECTIONS)
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
||
|
LIVERTOX |
NBK548862
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1010
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
SUB12496MIG
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
159519-65-0
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
100000089287
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
608828
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
C2105
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
DTXSID20166672
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
LL-10
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
7341
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
CHEMBL525076
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
8063
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
DB00109
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
139896
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | RxNorm | ||
|
m4906
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | Merck Index | ||
|
ENFUVIRTIDE
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
19OWO1T3ZE
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
Enfuvirtide
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
C105196
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY | |||
|
19OWO1T3ZE
Created by
admin on Sat Dec 16 16:21:25 UTC 2023 , Edited by admin on Sat Dec 16 16:21:25 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
Enfuvirtide binds to gp41 preventing the creation of an entry pore for the capsid of the virus, keeping it out of the cell.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Biological Half-life | PHARMACOKINETIC |
|
|
|||